Tetrahydrobiopterin in Cell Function and Death Mechanisms
Overview
Affiliations
Tetrahydrobiopterin (BH4) is most well known as a required cofactor for enzymes regulating cellular redox homeostasis, aromatic amino acid metabolism, and neurotransmitter synthesis. Less well known are the effects dependent on the cofactor's availability, factors governing its synthesis and recycling, redox implications of the cofactor itself, and protein-protein interactions that underlie cell death. This review provides an understanding of the recent advances implicating BH4 in the mechanisms of cell death and suggestions of possible therapeutic interventions. The levels of BH4 often reflect the sum of synthetic and recycling enzyme activities. Enhanced expression of GTP cyclohydrolase, the rate-limiting enzyme in biosynthesis, increases BH4, leading to improved cell function and survival. Pharmacologically increasing BH4 levels has similar beneficial effects, leading to enhanced production of neurotransmitters and nitric oxide or reducing oxidant levels. The GTP cyclohydrolase-BH4 pairing has been implicated in a type of cell death, ferroptosis. At the cellular level, BH4 counteracts anticancer therapies directed to enhance ferroptosis glutathione peroxidase 4 (GPX4) activity inhibition. Because of the multitude of intertwined mechanisms, a clear relationship between BH4 and cell death is not well understood yet. The possibility that the cofactor directly influences cell viability has not been excluded in previous studies when modulating BH4-producing enzymes. The importance of cellular BH4 variations and BH4 biosynthetic enzymes to cell function and viability makes it essential to better characterize temporal changes, cofactor activity, and the influence on redox status, which in turn would help develop novel therapies. . 37, 171-183.
Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment.
Rostami Ravari N, Sadri F, Mahdiabadi M, Mohammadi Y, Ourang Z, Rezaei Z Front Cell Dev Biol. 2025; 13:1522873.
PMID: 40078365 PMC: 11897296. DOI: 10.3389/fcell.2025.1522873.
Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.
PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.
Mechanisms of Vitamins Inhibiting Ferroptosis.
Zhang M, Chen X, Zhang Y Antioxidants (Basel). 2025; 13(12.
PMID: 39765898 PMC: 11673384. DOI: 10.3390/antiox13121571.
Kots A, Bian K Cells. 2024; 13(23).
PMID: 39682756 PMC: 11639989. DOI: 10.3390/cells13232008.
Ferroptosis in schizophrenia: Mechanisms and therapeutic potentials (Review).
Lv S, Luo C Mol Med Rep. 2024; 31(2).
PMID: 39611491 PMC: 11613623. DOI: 10.3892/mmr.2024.13402.